The global market for Ophthalmic Therapeutic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Therapeutic Drugs.

The Ophthalmic Therapeutic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ophthalmic Therapeutic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ophthalmic Therapeutic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ophthalmic Therapeutic Drugs Market Report

Report Metric	Details
Report Name	Ophthalmic Therapeutic Drugs Market
CAGR	5%
Segment by Type	Anti-inflammatory Drugs Anti-infective Drugs Anti-glaucoma Drugs Anti-allergy Drugs Anti-VEGF Agents Others
Segment by Application	Hospital Pharmacies Online Pharmacies Independent Pharmacies & Drug Stores
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Pfizer, Novartis, ALLERGAN, Aerie Pharmaceuticals, Bausch Health, Genentech, Regeneron Pharmaceuticals, Takeda, Santen Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ophthalmic Therapeutic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ophthalmic Therapeutic Drugs Market report?

Ans: The main players in the Ophthalmic Therapeutic Drugs Market are Bayer, Pfizer, Novartis, ALLERGAN, Aerie Pharmaceuticals, Bausch Health, Genentech, Regeneron Pharmaceuticals, Takeda, Santen Pharmaceutical

What are the Application segmentation covered in the Ophthalmic Therapeutic Drugs Market report?

Ans: The Applications covered in the Ophthalmic Therapeutic Drugs Market report are Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores

What are the Type segmentation covered in the Ophthalmic Therapeutic Drugs Market report?

Ans: The Types covered in the Ophthalmic Therapeutic Drugs Market report are Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Agents, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Anti-inflammatory Drugs

1.2.3 Anti-infective Drugs

1.2.4 Anti-glaucoma Drugs

1.2.5 Anti-allergy Drugs

1.2.6 Anti-VEGF Agents

1.2.7 Others

1.3 Market by Application

1.3.1 Global Ophthalmic Therapeutic Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Independent Pharmacies & Drug Stores

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ophthalmic Therapeutic Drugs Market Perspective (2020-2031)

2.2 Global Ophthalmic Therapeutic Drugs Growth Trends by Region

2.2.1 Global Ophthalmic Therapeutic Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Ophthalmic Therapeutic Drugs Historic Market Size by Region (2020-2025)

2.2.3 Ophthalmic Therapeutic Drugs Forecasted Market Size by Region (2026-2031)

2.3 Ophthalmic Therapeutic Drugs Market Dynamics

2.3.1 Ophthalmic Therapeutic Drugs Industry Trends

2.3.2 Ophthalmic Therapeutic Drugs Market Drivers

2.3.3 Ophthalmic Therapeutic Drugs Market Challenges

2.3.4 Ophthalmic Therapeutic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ophthalmic Therapeutic Drugs Players by Revenue

3.1.1 Global Top Ophthalmic Therapeutic Drugs Players by Revenue (2020-2025)

3.1.2 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Ophthalmic Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Ophthalmic Therapeutic Drugs Revenue

3.4 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio

3.4.1 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutic Drugs Revenue in 2024

3.5 Global Key Players of Ophthalmic Therapeutic Drugs Head office and Area Served

3.6 Global Key Players of Ophthalmic Therapeutic Drugs, Product and Application

3.7 Global Key Players of Ophthalmic Therapeutic Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Ophthalmic Therapeutic Drugs Breakdown Data by Type

4.1 Global Ophthalmic Therapeutic Drugs Historic Market Size by Type (2020-2025)

4.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Type (2026-2031)

5 Ophthalmic Therapeutic Drugs Breakdown Data by Application

5.1 Global Ophthalmic Therapeutic Drugs Historic Market Size by Application (2020-2025)

5.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Ophthalmic Therapeutic Drugs Market Size (2020-2031)

6.2 North America Ophthalmic Therapeutic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Ophthalmic Therapeutic Drugs Market Size by Country (2020-2025)

6.4 North America Ophthalmic Therapeutic Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ophthalmic Therapeutic Drugs Market Size (2020-2031)

7.2 Europe Ophthalmic Therapeutic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Ophthalmic Therapeutic Drugs Market Size by Country (2020-2025)

7.4 Europe Ophthalmic Therapeutic Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size (2020-2031)

8.2 Asia-Pacific Ophthalmic Therapeutic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Ophthalmic Therapeutic Drugs Market Size (2020-2031)

9.2 Latin America Ophthalmic Therapeutic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2020-2025)

9.4 Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size (2020-2031)

10.2 Middle East & Africa Ophthalmic Therapeutic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Ophthalmic Therapeutic Drugs Introduction

11.1.4 Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Ophthalmic Therapeutic Drugs Introduction

11.2.4 Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Ophthalmic Therapeutic Drugs Introduction

11.3.4 Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 ALLERGAN

11.4.1 ALLERGAN Company Details

11.4.2 ALLERGAN Business Overview

11.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Introduction

11.4.4 ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.4.5 ALLERGAN Recent Development

11.5 Aerie Pharmaceuticals

11.5.1 Aerie Pharmaceuticals Company Details

11.5.2 Aerie Pharmaceuticals Business Overview

11.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction

11.5.4 Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.5.5 Aerie Pharmaceuticals Recent Development

11.6 Bausch Health

11.6.1 Bausch Health Company Details

11.6.2 Bausch Health Business Overview

11.6.3 Bausch Health Ophthalmic Therapeutic Drugs Introduction

11.6.4 Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.6.5 Bausch Health Recent Development

11.7 Genentech

11.7.1 Genentech Company Details

11.7.2 Genentech Business Overview

11.7.3 Genentech Ophthalmic Therapeutic Drugs Introduction

11.7.4 Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.7.5 Genentech Recent Development

11.8 Regeneron Pharmaceuticals

11.8.1 Regeneron Pharmaceuticals Company Details

11.8.2 Regeneron Pharmaceuticals Business Overview

11.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction

11.8.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.8.5 Regeneron Pharmaceuticals Recent Development

11.9 Takeda

11.9.1 Takeda Company Details

11.9.2 Takeda Business Overview

11.9.3 Takeda Ophthalmic Therapeutic Drugs Introduction

11.9.4 Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.9.5 Takeda Recent Development

11.10 Santen Pharmaceutical

11.10.1 Santen Pharmaceutical Company Details

11.10.2 Santen Pharmaceutical Business Overview

11.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Introduction

11.10.4 Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025)

11.10.5 Santen Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Aerie Pharmaceuticals

Bausch Health

Genentech Inc

Regeneron Pharmaceuticals

Takeda

Santen Pharmaceutical

List of Tables

Table 1. Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Anti-inflammatory Drugs

Table 3. Key Players of Anti-infective Drugs

Table 4. Key Players of Anti-glaucoma Drugs

Table 5. Key Players of Anti-allergy Drugs

Table 6. Key Players of Anti-VEGF Agents

Table 7. Key Players of Others

Table 8. Global Ophthalmic Therapeutic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Ophthalmic Therapeutic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Ophthalmic Therapeutic Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Ophthalmic Therapeutic Drugs Market Share by Region (2020-2025)

Table 12. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Ophthalmic Therapeutic Drugs Market Share by Region (2026-2031)

Table 14. Ophthalmic Therapeutic Drugs Market Trends

Table 15. Ophthalmic Therapeutic Drugs Market Drivers

Table 16. Ophthalmic Therapeutic Drugs Market Challenges

Table 17. Ophthalmic Therapeutic Drugs Market Restraints

Table 18. Global Ophthalmic Therapeutic Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Ophthalmic Therapeutic Drugs Market Share by Players (2020-2025)

Table 20. Global Top Ophthalmic Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Therapeutic Drugs as of 2024)

Table 21. Ranking of Global Top Ophthalmic Therapeutic Drugs Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Ophthalmic Therapeutic Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Ophthalmic Therapeutic Drugs, Headquarters and Area Served

Table 24. Global Key Players of Ophthalmic Therapeutic Drugs, Product and Application

Table 25. Global Key Players of Ophthalmic Therapeutic Drugs, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Ophthalmic Therapeutic Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2020-2025)

Table 29. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2026-2031)

Table 31. Global Ophthalmic Therapeutic Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Application (2020-2025)

Table 33. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Application (2026-2031)

Table 35. North America Ophthalmic Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Ophthalmic Therapeutic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Ophthalmic Therapeutic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Ophthalmic Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Ophthalmic Therapeutic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Ophthalmic Therapeutic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Ophthalmic Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 50. Bayer Company Details

Table 51. Bayer Business Overview

Table 52. Bayer Ophthalmic Therapeutic Drugs Product

Table 53. Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 54. Bayer Recent Development

Table 55. Pfizer Company Details

Table 56. Pfizer Business Overview

Table 57. Pfizer Ophthalmic Therapeutic Drugs Product

Table 58. Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 59. Pfizer Recent Development

Table 60. Novartis Company Details

Table 61. Novartis Business Overview

Table 62. Novartis Ophthalmic Therapeutic Drugs Product

Table 63. Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 64. Novartis Recent Development

Table 65. ALLERGAN Company Details

Table 66. ALLERGAN Business Overview

Table 67. ALLERGAN Ophthalmic Therapeutic Drugs Product

Table 68. ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 69. ALLERGAN Recent Development

Table 70. Aerie Pharmaceuticals Company Details

Table 71. Aerie Pharmaceuticals Business Overview

Table 72. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Product

Table 73. Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 74. Aerie Pharmaceuticals Recent Development

Table 75. Bausch Health Company Details

Table 76. Bausch Health Business Overview

Table 77. Bausch Health Ophthalmic Therapeutic Drugs Product

Table 78. Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 79. Bausch Health Recent Development

Table 80. Genentech Company Details

Table 81. Genentech Business Overview

Table 82. Genentech Ophthalmic Therapeutic Drugs Product

Table 83. Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 84. Genentech Recent Development

Table 85. Regeneron Pharmaceuticals Company Details

Table 86. Regeneron Pharmaceuticals Business Overview

Table 87. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Product

Table 88. Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 89. Regeneron Pharmaceuticals Recent Development

Table 90. Takeda Company Details

Table 91. Takeda Business Overview

Table 92. Takeda Ophthalmic Therapeutic Drugs Product

Table 93. Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 94. Takeda Recent Development

Table 95. Santen Pharmaceutical Company Details

Table 96. Santen Pharmaceutical Business Overview

Table 97. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Product

Table 98. Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2020-2025) & (US$ Million)

Table 99. Santen Pharmaceutical Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Ophthalmic Therapeutic Drugs Picture

Figure 2. Global Ophthalmic Therapeutic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ophthalmic Therapeutic Drugs Market Share by Type: 2024 VS 2031

Figure 4. Anti-inflammatory Drugs Features

Figure 5. Anti-infective Drugs Features

Figure 6. Anti-glaucoma Drugs Features

Figure 7. Anti-allergy Drugs Features

Figure 8. Anti-VEGF Agents Features

Figure 9. Others Features

Figure 10. Global Ophthalmic Therapeutic Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Ophthalmic Therapeutic Drugs Market Share by Application: 2024 VS 2031

Figure 12. Hospital Pharmacies Case Studies

Figure 13. Online Pharmacies Case Studies

Figure 14. Independent Pharmacies & Drug Stores Case Studies

Figure 15. Ophthalmic Therapeutic Drugs Report Years Considered

Figure 16. Global Ophthalmic Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Ophthalmic Therapeutic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Ophthalmic Therapeutic Drugs Market Share by Region: 2024 VS 2031

Figure 19. Global Ophthalmic Therapeutic Drugs Market Share by Players in 2024

Figure 20. Global Top Ophthalmic Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Therapeutic Drugs as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Ophthalmic Therapeutic Drugs Revenue in 2024

Figure 22. North America Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Ophthalmic Therapeutic Drugs Market Share by Country (2020-2031)

Figure 24. United States Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Ophthalmic Therapeutic Drugs Market Share by Country (2020-2031)

Figure 28. Germany Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Ophthalmic Therapeutic Drugs Market Share by Region (2020-2031)

Figure 36. China Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Ophthalmic Therapeutic Drugs Market Share by Country (2020-2031)

Figure 44. Mexico Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Ophthalmic Therapeutic Drugs Market Share by Country (2020-2031)

Figure 48. Turkey Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Ophthalmic Therapeutic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Bayer Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 54. ALLERGAN Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 55. Aerie Pharmaceuticals Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 56. Bausch Health Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 57. Genentech Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 59. Takeda Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 60. Santen Pharmaceutical Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions